Evidence map›Paper›PMID 31448551›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2019

Prevalence of hypertension and cardiovascular risk factors among long-term AIDS survivors: A report from the field.

Samuel Pierre, Grace Seo, Vanessa R Rivera, Kathleen F Walsh, Jean Joscar Victor, Benedict Charles, Gaetane Julmiste, Emelyne Dumont, Alexandra Apollon, Molene Cadet and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Samuel PierreHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Grace SeoHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.ORCID 0000-0002-6503-7192
Vanessa R RiveraHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Kathleen F WalshDepartment of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Jean Joscar VictorHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Benedict CharlesHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Gaetane JulmisteHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Emelyne DumontHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Alexandra ApollonHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Molene CadetHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Alix Saint-VilHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Adias MarcelinHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Patrice SevereHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Myung Hee LeeDepartment of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Justin KingeryDepartment of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Serena KoenigBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Daniel FitzgeraldDepartment of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Jean PapeHaitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Margaret L McNairyDepartment of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Gheskio Centers · HTCornell University · USBrigham and Women's Hospital · US

Funding

GHESKIO HIV Clinical Trial UnitUM1AI069421 · NIAID · GHESKIO CENTER · PI JEAN WILLIAM PAPE · 2012 to 2026
$23.6M
Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep DisordersR01HL143788 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Margaret Leighton McNairy · 2018 to 2026
$8.9M
Vanderbilt-Emory-Cornell-Duke Global Health Fellowship Consortium-Expanding Diversity for Global Equity (EDGE)D43TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALIYU, MUKTAR HASSAN, HEIMBURGER, DOUGLAS CORBETT · 2017 to 2021
$6.3M
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
FIC NIH HHS D43 TW009337FIC NIH HHS R25 TW009337NHLBI NIH HHS R01 HL143788NIAID NIH HHS UM1 AI069421
6 · The paper itself

Abstract

HIV infection is associated with increased risk and progression of cardiovascular disease (CVD), yet little is known about the prevalence of CVD risk factors among long-term AIDS survivors in resource-limited settings. Using routinely collected data, we conducted a retrospective study to describe the prevalence of CVD risk factors among a cohort of HIV-infected patients followed for over 10 years in Port-au Prince, Haiti. This cohort includes 910 adults who initiated antiretroviral therapy (ART) between 2003 and 2004 and remained in care between 2014 and 2016 when routine screening for CVD risk factors was implemented at a large clinic in Haiti. A total of 397 remained in care ≥10 years and received screening. At ART initiation, 59% were female, median age was 38 years (IQR 33-44), and median CD4 count was 117 cells/mm

Indexed as

Acquired Immunodeficiency SyndromeAdultAnti-Retroviral AgentsCardiovascular DiseasesCD4 Lymphocyte CountDiabetes MellitusDiagnostic Screening ProgramsFemaleHaitiHIV-1HIV InfectionsHumansHypercholesterolemiaHypertensionMaleMiddle AgedAnti-Retroviral Agentsagingcardiovascular diseaseHIVhypertensionrisk assessment

Identifiers

PMID31448551
PMCPMC6896990
OpenAlexW2970204131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.